Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3644522
Max Phase: Preclinical
Molecular Formula: C20H19N5
Molecular Weight: 329.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3644522
Max Phase: Preclinical
Molecular Formula: C20H19N5
Molecular Weight: 329.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCc1nc(N)nc(N)c1C#CCc1cccc(-c2cccnc2)c1
Standard InChI: InChI=1S/C20H19N5/c1-2-18-17(19(21)25-20(22)24-18)10-4-7-14-6-3-8-15(12-14)16-9-5-11-23-13-16/h3,5-6,8-9,11-13H,2,7H2,1H3,(H4,21,22,24,25)
Standard InChI Key: IXYIZEGMHCDBOH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 329.41 | Molecular Weight (Monoisotopic): 329.1640 | AlogP: 2.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 90.71 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.12 | CX LogP: 3.49 | CX LogD: 3.31 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -0.73 |
1. (2014) Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase, |
Source(1):